Biogen Inc. Completes Acquisition of Human Immunology Biosciences (HI-Bio™)

Biogen Inc. has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company foc...

July 03, 2024 | Wednesday | News
Merck and and Orion Announce Exercise of Option for Exclusive Global License of Opevesostat, Advancing Prostate Cancer Treatment

Merck  known as MSD outside of the United States and Canada, and Orion Corporation announced that notice has been provided of the mutual exercise of...

July 02, 2024 | Tuesday | News
Dawn Health Partners with Merck to Develop Digital Solution for Growth Hormone Disorders

Dawn Health, the digital health company pioneering patient-first innovation, has announced they are working with leading global pharmaceutical company, M...

July 01, 2024 | Monday | News
Moderna’s mRESVIA Receives Positive CHMP Opinion for RSV Vaccine in Adults 60+

Moderna,  announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion ...

July 01, 2024 | Monday | News
Bio-Rad Launches Celselect Slides 2.0 to Enhance Rare Cell and CTC Capture

Bio-Rad Laboratories,  a global leader in life science research and clinical diagnostics products, today announced the launch of Celselect Slides 2....

July 01, 2024 | Monday | News
AbbVie Acquires Celsius Therapeutics to Advance Innovative IBD Treatments

AbbVie (NYSE: ABBV) announced  the acquisition of Celsius Therapeutics, Inc. ("Celsius"), a privately held biotechnology company pioneering new...

June 28, 2024 | Friday | News
Thermo Fisher Scientific’s PPD Clinical Research Business to Expand Kentucky Labs, Adding Over 250 Jobs

The PPD clinical research business will nearly double its laboratory footprint in northern Kentucky, add more than 250 jobs The PPD clinical research bu...

June 28, 2024 | Friday | News
WHO Awards Prequalification to Roche's HPV Test for Broad Use, Enhancing Global Cervical Cancer Screening

The World Health Organization (WHO) has awarded Roche's human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System ...

June 27, 2024 | Thursday | News
Bio-Rad Laboratories Launches New Anti-Idiotypic and Anti-MMAE Antibodies for Enhanced Bioanalytical Assays

  Bio-Rad Laboratories,  a global leader in life science research and clinical diagnostics products, today launched four new anti-idiotypic anti...

June 25, 2024 | Tuesday | News
BioNTech and DualityBio's ADC Candidate BNT324/DB-1311 Gains FDA Fast-Track Status for Prostate Cancer

The status is based on preclinical data and data from an ongoing phase 1/2 study for BNT324/DB-1311; preliminary phase 1/2 clinical data showed anti-tu...

June 25, 2024 | Tuesday | News
Johnson & Johnson Completes Acquisition of Proteologix, Inc. for $850 Million

Johnson & Johnson  announced  that it has successfully completed the acquisition of Proteologix, Inc., a privately-held biotechnology compa...

June 24, 2024 | Monday | News
Roche Introduces cobas® c 703 and cobas® ISE neo for Streamlined Lab Operations

The cobas® c 703 and cobas® ISE neo analytical units, deliver higher testing capacity and increased automation helping to improve laboratory wo...

June 24, 2024 | Monday | News
Bora Pharmaceuticals Expands US Presence with Acquisition of Emergent BioSolutions’ Sterile Manufacturing Facility in Baltimore

Bora Pharmaceuticals Co., Ltd.  announced that it has successfully entered into an agreement for Emergent BioSolutions’  sterile man...

June 21, 2024 | Friday | News
Roche Launches First Clinically Approved ISH Test for Comprehensive B-Cell Lymphoma Diagnosis

The VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay is the first clinically approved in-situ hybridisation (ISH) test with the sensitivity ...

June 20, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close